251 related articles for article (PubMed ID: 30513238)
1. Prospects for rotavirus vaccine introduction in the Philippines: Bridging the available evidence into immunization policy.
Lopez AL; Raguindin PF; Silva MWT
Hum Vaccin Immunother; 2019; 15(6):1260-1264. PubMed ID: 30513238
[TBL] [Abstract][Full Text] [Related]
2. Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan.
Anwari P; Debellut F; Pecenka C; Parwiz SM; Clark A; Groman D; Safi N
Vaccine; 2018 Dec; 36(51):7769-7774. PubMed ID: 29107346
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran.
Javanbakht M; Moradi-Lakeh M; Yaghoubi M; Esteghamati A; Mansour Ghanaie R; Mahmoudi S; Shamshiri AR; Zahraei SM; Baxter L; Shakerian S; Chaudhri I; Fleming JA; Munier A; Baradaran HR
Vaccine; 2015 May; 33 Suppl 1():A192-200. PubMed ID: 25919160
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of rotavirus vaccination in Turkey.
Koksal T; Akelma AZ; Koksal AO; Kutukoglu I; Ozdemir O; Yuksel CN; Bozkaya D; Catal F; Sari S
J Microbiol Immunol Infect; 2017 Oct; 50(5):693-699. PubMed ID: 27107612
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
[TBL] [Abstract][Full Text] [Related]
6. Effects of geographic and economic heterogeneity on rotavirus diarrhea burden and vaccination impact and cost-effectiveness in the Lao People's Democratic Republic.
Rheingans R; Anderson JD; Bagamian KH; Pecenka CJ
Vaccine; 2018 Dec; 36(51):7868-7877. PubMed ID: 30007827
[TBL] [Abstract][Full Text] [Related]
7. Impact of rotavirus vaccine on diarrheal hospitalization and outpatient consultations in the Philippines: First evidence from a middle-income Asian country.
Lopez AL; Raguindin PF; Esparagoza J; Fox K; Batmunkh N; Bonifacio J; Parashar UD; Tate JE; Ducusin MJ
Vaccine; 2018 May; 36(23):3308-3314. PubMed ID: 29729994
[TBL] [Abstract][Full Text] [Related]
8. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.
Muangchana C; Riewpaiboon A; Jiamsiri S; Thamapornpilas P; Warinsatian P
Vaccine; 2012 Apr; 30(18):2839-47. PubMed ID: 22387220
[TBL] [Abstract][Full Text] [Related]
9. Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.
Tate JE; Patel MM; Cortese MM; Lopman BA; Gentsch JR; Fleming J; Steele AD; Parashar UD
Expert Rev Vaccines; 2012 Feb; 11(2):211-20. PubMed ID: 22309669
[TBL] [Abstract][Full Text] [Related]
10. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan.
Rheingans R; Anderson JD; Bagamian KH; Laytner LA; Pecenka CJ; Gilani SSA; Ahmed M
Vaccine; 2018 Dec; 36(51):7780-7789. PubMed ID: 30007826
[TBL] [Abstract][Full Text] [Related]
11. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria.
Anderson JD; Pecenka CJ; Bagamian KH; Rheingans RD
PLoS One; 2020; 15(5):e0232941. PubMed ID: 32469927
[TBL] [Abstract][Full Text] [Related]
12. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
[TBL] [Abstract][Full Text] [Related]
13. Economic evaluation of rotavirus vaccination: an important step of the introduction to the national immunization program in Thailand.
Rochanathimoke O; Riewpaiboon A; Praditsitthikorn N; Tharmaphornpilas P; Jiamsiri S; Thavorncharoensap M; Postma MJ
Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):811-819. PubMed ID: 34008471
[TBL] [Abstract][Full Text] [Related]
14. A review of rotavirus vaccine use in Asia and the Pacific regions: challenges and future prospects.
Buchy P; Chen J; Zhang XH; Benninghoff B; Lee C; Bibera GL
Expert Rev Vaccines; 2021 Dec; 20(12):1499-1514. PubMed ID: 33275065
[TBL] [Abstract][Full Text] [Related]
15. Rotavirus vaccination in Central American children.
Ulloa-Gutierrez R; Avila-Aguero ML
Expert Rev Vaccines; 2014 Jun; 13(6):687-90. PubMed ID: 24702467
[TBL] [Abstract][Full Text] [Related]
16. Rotavirus vaccines: targeting the developing world.
Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
[TBL] [Abstract][Full Text] [Related]
17. Rotavirus: Genetics, pathogenesis and vaccine advances.
Sadiq A; Bostan N; Yinda KC; Naseem S; Sattar S
Rev Med Virol; 2018 Nov; 28(6):e2003. PubMed ID: 30156344
[TBL] [Abstract][Full Text] [Related]
18. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the first introduction of rotavirus vaccine in Thailand: Moving from evidence to policy.
Tharmaphornpilas P; Jiamsiri S; Boonchaiya S; Rochanathimoke O; Thinyounyong W; Tuntiwitayapun S; Guntapong R; Riewpaiboon A; Rasdjarmrearnsook AO; Glass RI
Vaccine; 2017 Feb; 35(5):796-801. PubMed ID: 28057385
[TBL] [Abstract][Full Text] [Related]
20. An overview of rotavirus vaccination programs in developing countries.
Hallowell BD; Tate J; Parashar U
Expert Rev Vaccines; 2020 Jun; 19(6):529-537. PubMed ID: 32543239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
